Literature DB >> 22507047

Abnormal epidermal barrier in the pathogenesis of psoriasis.

Ronni Wolf1, Edith Orion, Eleonora Ruocco, Vincenzo Ruocco.   

Abstract

Almost 2 decades ago, Williams and Elias suggested a unifying concept for the pathogenesis of disorders of cornification, according to which the integrity of the epidermal barrier and its effective function is an important factor in the regulation of epidermal DNA synthesis. Interference with the barrier integrity or function will result in epidermal hyperplasia and may be the primary event leading to hyperproliferative skin diseases, such as psoriasis. We have analyzed alterations to several structures of the epidermal barrier that might be responsible for barrier dysfunction and thus lead to hyperproliferation of the epidermis in an attempt to repair the barrier and, as a result, might be inducers of psoriasis. There are several convincing reports indicating that inhibiting of epidermal transglutaminase may lead to epidermal hyperproliferation and that this stimulus might trigger psoriasis among genetically predisposed patients. Disturbance of epidermal barrier function caused by derangement of lipid or cholesterol or ceramide synthesis leads to increased DNA synthesis and epidermal hyperplasia and as a result might be an inducer of psoriasis. We could find little evidence to show that defective defense of the epidermis or an abnormal response of it to bacteria plays a role in the pathogenesis of psoriasis. Accumulating data indicate that there is an association of psoriasis and mutations of genes within the epidermal differentiation complex, which are crucial for the development, maturation, cornification, cross-linking, and terminal differentiation of the epidermis, called psoriasis susceptibility locus 4.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22507047     DOI: 10.1016/j.clindermatol.2011.08.022

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  22 in total

1.  A GRHL3-regulated repair pathway suppresses immune-mediated epidermal hyperplasia.

Authors:  William M Gordon; Michael D Zeller; Rachel H Klein; William R Swindell; Hsiang Ho; Francisco Espetia; Johann E Gudjonsson; Pierre F Baldi; Bogi Andersen
Journal:  J Clin Invest       Date:  2014-10-27       Impact factor: 14.808

2.  Interferon-γ decreases ceramides with long-chain fatty acids: possible involvement in atopic dermatitis and psoriasis.

Authors:  Chisato Tawada; Hiroyuki Kanoh; Mitsuhiro Nakamura; Yoko Mizutani; Tomomi Fujisawa; Yoshiko Banno; Mariko Seishima
Journal:  J Invest Dermatol       Date:  2013-09-05       Impact factor: 8.551

3.  TLR3: a receptor that recognizes cell injury is essential for permeability barrier homeostasis following UV irradiation.

Authors:  Kenneth R Feingold
Journal:  J Invest Dermatol       Date:  2015-02       Impact factor: 8.551

4.  In Vitro Modeling of Skin Barrier Disruption and its Recovery by Ceramide-Based Formulations.

Authors:  Barbora Amélie Čuříková-Kindlová; Aneta Vovesná; Anna Nováčková; Jarmila Zbytovská
Journal:  AAPS PharmSciTech       Date:  2021-12-14       Impact factor: 3.246

Review 5.  Mechanotransduction in Skin Inflammation.

Authors:  Maria S Shutova; Wolf-Henning Boehncke
Journal:  Cells       Date:  2022-06-25       Impact factor: 7.666

Review 6.  The role of xenobiotics in triggering psoriasis.

Authors:  Jasna Grželj; Marija Sollner Dolenc
Journal:  Arch Toxicol       Date:  2020-08-24       Impact factor: 5.153

Review 7.  The role of sterol-C4-methyl oxidase in epidermal biology.

Authors:  Miao He; Laurie D Smith; Richard Chang; Xueli Li; Jerry Vockley
Journal:  Biochim Biophys Acta       Date:  2013-10-18

8.  Pathological role of excessive DNA as a trigger of keratinocyte proliferation in psoriasis.

Authors:  Y Luo; T Hara; A Kawashima; Y Ishido; S Suzuki; N Ishii; T Kambara; K Suzuki
Journal:  Clin Exp Immunol       Date:  2020-06-08       Impact factor: 4.330

Review 9.  Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue Targeting.

Authors:  Brian C Palmer; Lisa A DeLouise
Journal:  Molecules       Date:  2016-12-15       Impact factor: 4.411

10.  Cellular dissection of psoriasis for transcriptome analyses and the post-GWAS era.

Authors:  William R Swindell; Philip E Stuart; Mrinal K Sarkar; John J Voorhees; James T Elder; Andrew Johnston; Johann E Gudjonsson
Journal:  BMC Med Genomics       Date:  2014-05-22       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.